Find any stock by ticker or company name
Barcha huquqlar himoyalangan.
12.60
0.00 (0.00%)
Convatec Group PLC (CNVVY) Q2 2026 Earnings Call Transcript
ConvaTec Group LON: CTEC said it remained on track to meet its 2026 financial targets after reporting 5% organic revenue growth in the first half, excluding the impact of its InnovaMatrix skin-substitute product.
British medical products maker Convatec on Tuesday forecast its second-half operating margin to be materially higher than the first half, and pointed to accelerating demand for its infusion care products.
There is no data to display
